1-EBIO | 1-Ethylbenzimidazolinone |
2-APB | 2-aminoethoxydiphenyl borate |
4-AP | 4-aminopyridine |
Å | Angstrom (unit of length equal to 10−10 m) |
aa | Amino acid |
AC8 | Adenylyl cyclase 8 |
Akt | Known as protein kinase B or PKB |
ARC | Arachidonic acid (AA)-activated channels |
ATP | Adenosine triphosphate |
ANSGA | 4-Point mutation in hinge region aa position 261–265 |
ATPase | Adenosine triphosphatase |
BK | Large conductance, Ca2+-activated potassium channels |
BTP2 | [N-{4-[3,5-bis(Trifluoromethyl)-1H-pyrazol-1-yl]phenyl}-4-methyl-1,2,3-thiadiazole-5-carboxamide] |
Ca2+ | Calcium ion |
CAD | Ca2+ release-activated Ca2+-activating domain |
CaM | Calmodulin |
cAMP | Cyclic adenosine monophosphate |
CAR | Ca2+ accumulating region |
CaV1 | Caveolin-1 |
CC | Coiled-coil |
Ccb9 | Coiled-coil domain containing region b9 |
cEF | Canonical EF hand |
CRAC | Ca2+ release-activated Ca2+ |
CRACR2A | Calcium release activated channel regulator 2A |
CRISPR/Cas9 | Clustered regularly interspaced short palindromic repeats/Cas |
Cs+ | Cesium ion |
Cyppa | N-Cyclohexyl-N-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-4 pyrimidinamine |
∆ | Represents deletion mutants |
dOrai | Drosophila melanogaster Orai |
DVF | Divalent-free |
EDA | Ectodermal dysplasia |
EGF | Epidermal growth factor |
EGTA | Ethylene glycol tetraacetic acid |
ER | Endoplasmic reticulum |
ERα | Estrogen receptor-α |
ERK1/2 | Extracellular-signal-regulated kinases 1 and 2 |
ETON | Extended transmembrane Orai1 N-terminal |
FCDI | Fast calcium-dependent inactivation |
FRAP | Fluorescence recovery after photobleaching |
FRET | Fluorescence resonance energy transfer |
GBM | Glioblastoma multiforme cells |
GoF | Gain of function |
GSK | GlaxoSmithKline compounds |
HEK | Human embryonic kidney |
I/V | Current voltage relationship |
ICa2+ | CRAC current |
INa+ | Sodium current in sodium divalent free solution |
ID | Inhibitory domain |
IH | Inhibitory helix |
IK | Intermediate Ca2+-activated K+ channels |
IP3 | Inositol-triphosphate |
IP3R | Inositol-triphosphate receptor |
K+ | Potassium ion |
KCa | Ca2+-activated K+ channels |
Kir | Inward-rectifier potassium channels |
L1-L3 | Loop 1–3 (of Orai channels) |
L-type | Long-lasting calcium channel |
LGC | Ligand gated calcium channels |
LoF | Loss of function |
MCU | Mitochondrial Ca2+ uniporter |
MD simulations | Molecular dynamics simulations |
Na+-DVF | Sodium divalent free |
nEF | Non-canonical EF hand |
NFAT | Nuclear factor of activated T cells |
nAChR | Nicotinic acetylcholine receptors |
NS309 | 3-Oxime-6,7-dichloro-1H-indole-2,3-dione |
NS3893 | N-[(1R)-1,2,3,4-Tetrahydro-1-naphthalenyl]-1H-Benzimidazol-2-amine hydrochloride |
NMR | Nuclear magnetic resonance |
OASF | Orai-activating small fragment |
Orai 1–3 | Orai proteins (also as O1–3) |
P/S | Proline, serine |
P-Akt | Phosphorylated known as protein kinase B or PKB |
PI3K | Phosphoinositide 3-kinases |
PIP2 | Phosphatidylinositol 4,5-bisphosphate |
PKA | Protein kinase A |
PKC | Protein kinase C |
PM | Plasma membrane |
PMCA | Plasma membrane Ca2+ ATPase |
Ref | References |
S | Signal peptide |
SAM | sterile α-motif |
SARAF | Store-operated calcium entry associated regulatory factor |
SCDI | Slow calcium-dependent inactivation |
SCID | Severe combined immune deficiency |
SigmaR1 | Sigma non-Opioid intracellular receptor 1 |
SK channels | Small-conductance Ca(2+)-activated K(+) channels |
SKA-111 | 5-Methylnaphtho[1¨C-d]thiazol-2-amine |
SKA-121 | 5-Methylnaphth[2,1-d]oxazol-2-amine |
SOAP | STIM-Orai association pocket |
SOAR | STIM-Orai activating region |
SOC | Store operated channel |
SOCE | Store-operated calcium entry |
SPCA2 | Secretory pathway Ca2+-ATPase |
STIM | Stromal interaction molecule |
STRMK | Stormorken syndrome |
Synta66 | 4-Pyridinecarboxamide |
TAM | Tubular Aggregate Myopathy |
TM | Transmembrane helices |
TRP | Transient receptor potential ion channel (C-canonical, M-melastatin, V-vallinoid) |
VGCC | Voltage gated calcium channels |